Targeting the Mesentery in Crohn's Disease - Medscape medscape.com

Targeting the Mesentery in Crohn's Disease - Medscape

2 min read
Procedures and surgery Bowel Resection Post Surgical Recurrence Fistula Abscess Clinical study Clinicians Researchers
Why This Matters

Surgical technique after ileocolic resection may influence how likely Crohn’s disease is to come back near the anastomosis.

Newer approaches that target the mesentery (Kono-S anastomosis or more extensive mesenteric excision) are being studied because they might reduce postoperative recurrence and the need for further interventions.

Who Should Pay Attention

Patients with ileocolic Crohn’s disease facing surgery, colorectal surgeons and gastroenterologists, clinicians managing postoperative recurrence, and researchers studying surgical outcomes in IBD.

What To Know

This Medscape commentary reviews surgical approaches that target the mesentery in ileocolic Crohn’s disease, focusing on the Kono-S anastomosis and mesenteric excision as strategies to reduce postoperative recurrence.

The author explains goals of surgery, differences in anastomosis types, the rationale that mesenteric tissue may harbor proinflammatory signals driving recurrence, and references emerging studies and meta-analyses comparing outcomes. The article summarizes two mesenteric-targeted surgical concepts.

The Kono-S is a specific anastomotic technique that positions the lumen away from the mesentery and has been associated in some studies with lower endoscopic and surgical recurrence.

Mesenteric excision removes more mesenteric tissue at the time of ileocolic resection, based on the hypothesis that the mesentery can act as a reservoir for inflammation; early single-center and retrospective data reported improved postoperative outcomes, and this approach is being further studied.

The piece describes ongoing debate and evolving evidence rather than definitive practice-changing results. It highlights that many data are from single-center or nonrandomized studies and notes that surgeons are applying concepts from oncologic mesenteric excision to Crohn’s disease.

The commentary is aimed at clinicians and surgeons and references existing trials and meta-analyses without giving clinical recommendations.

Keep In Mind

This is an expert commentary summarizing evolving surgical strategies and published studies; much of the evidence cited includes single-center, retrospective data, early trials, and meta-analyses with heterogenous methods. The article does not provide practice-changing guidelines and does not replace individualized surgical decision-making.

Readers should consult primary studies and clinical guidelines and discuss options with their surgical team.

This Cure8 note is AI-assisted and based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Read Original Article Originally published May 5, 2026, 2:16 PM
Advertisement Space

Related Articles